List of Excipients in API diatrizoate meglumine and diatrizoate sodium
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing diatrizoate meglumine and diatrizoate sodium
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bracco Diagnostics Inc | GASTROGRAFIN | diatrizoate meglumine and diatrizoate sodium | 0270-0445 | EDETATE DISODIUM | |
| Bracco Diagnostics Inc | GASTROGRAFIN | diatrizoate meglumine and diatrizoate sodium | 0270-0445 | SACCHARIN SODIUM | |
| Bracco Diagnostics Inc | GASTROGRAFIN | diatrizoate meglumine and diatrizoate sodium | 0270-0445 | SODIUM CITRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing diatrizoate meglumine and diatrizoate sodium
Detailed excipient profiles for diatrizoate meglumine and diatrizoate sodium
Excipient focus: DIMETHICONE
diatrizoate meglumine and diatrizoate sodium drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | diatrizoate meglumine and diatrizoate sodium | 31722-019 |
| Guardian Drug Company | diatrizoate meglumine and diatrizoate sodium | 53041-690 |
| >Company | >Ingredient | >NDC |
diatrizoate meglumine and diatrizoate sodium drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Liebel-Flarsheim Company LLC | diatrizoate meglumine and diatrizoate sodium | 0019-4816 |
| Bracco Diagnostics Inc | diatrizoate meglumine and diatrizoate sodium | 0270-0445 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
diatrizoate meglumine and diatrizoate sodium drug variants containing EDETATE DISODIUM
diatrizoate meglumine and diatrizoate sodium drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
diatrizoate meglumine and diatrizoate sodium drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Guardian Drug Company | diatrizoate meglumine and diatrizoate sodium | 53041-690 |
| >Company | >Ingredient | >NDC |
diatrizoate meglumine and diatrizoate sodium drug variants not containing HYDROCHLORIC ACID
Excipient focus: POLYSORBATE 80
diatrizoate meglumine and diatrizoate sodium drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | diatrizoate meglumine and diatrizoate sodium | 31722-019 |
| Guardian Drug Company | diatrizoate meglumine and diatrizoate sodium | 53041-690 |
| >Company | >Ingredient | >NDC |
diatrizoate meglumine and diatrizoate sodium drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Liebel-Flarsheim Company LLC | diatrizoate meglumine and diatrizoate sodium | 0019-4816 |
| Bracco Diagnostics Inc | diatrizoate meglumine and diatrizoate sodium | 0270-0445 |
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
diatrizoate meglumine and diatrizoate sodium drug variants containing SACCHARIN SODIUM
diatrizoate meglumine and diatrizoate sodium drug variants not containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
diatrizoate meglumine and diatrizoate sodium drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Guardian Drug Company | diatrizoate meglumine and diatrizoate sodium | 53041-690 |
| >Company | >Ingredient | >NDC |
diatrizoate meglumine and diatrizoate sodium drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CITRATE
diatrizoate meglumine and diatrizoate sodium drug variants containing SODIUM CITRATE
diatrizoate meglumine and diatrizoate sodium drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | diatrizoate meglumine and diatrizoate sodium | 31722-019 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
diatrizoate meglumine and diatrizoate sodium drug variants containing SODIUM HYDROXIDE
diatrizoate meglumine and diatrizoate sodium drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bracco Diagnostics Inc | diatrizoate meglumine and diatrizoate sodium | 0270-0445 |
| >Company | >Ingredient | >NDC |
Excipient focus: STRAWBERRY
diatrizoate meglumine and diatrizoate sodium drug variants containing STRAWBERRY
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | diatrizoate meglumine and diatrizoate sodium | 31722-019 |
| >Company | >Ingredient | >NDC |
diatrizoate meglumine and diatrizoate sodium drug variants not containing STRAWBERRY
Excipient focus: TRISODIUM CITRATE DIHYDRATE
diatrizoate meglumine and diatrizoate sodium drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | diatrizoate meglumine and diatrizoate sodium | 31722-019 |
| >Company | >Ingredient | >NDC |
diatrizoate meglumine and diatrizoate sodium drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
diatrizoate meglumine and diatrizoate sodium drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Liebel-Flarsheim Company LLC | diatrizoate meglumine and diatrizoate sodium | 0019-4816 |
| Guardian Drug Company | diatrizoate meglumine and diatrizoate sodium | 53041-690 |
| >Company | >Ingredient | >NDC |
diatrizoate meglumine and diatrizoate sodium drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Bracco Diagnostics Inc | diatrizoate meglumine and diatrizoate sodium | 0270-0445 |
| Camber Pharmaceuticals Inc | diatrizoate meglumine and diatrizoate sodium | 31722-019 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
